| 1 |
30837643 | Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo. | 2019 Mar 5 |
2 |
| 2 |
30103170 | Metronomic oral doxorubicin in combination of Chk1 inhibitor MK-8776 for p53-deficient breast cancer treatment. | 2018 Nov |
5 |
| 3 |
28888100 | Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells. | 2017 Oct |
1 |
| 4 |
27556692 | Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cells. | 2016 Sep 20 |
2 |
| 5 |
27690219 | MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells. | 2016 Nov 1 |
1 |
| 6 |
23536721 | The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repair. | 2013 Jun |
1 |
| 7 |
24113549 | CHK1 levels correlate with sensitization to pemetrexed by CHK1 inhibitors in non-small cell lung cancer cells. | 2013 Dec |
1 |